Welcome to HemaCare Corporation – a leading global provider of biological blood products and services.
HemaCare is a global provider of human hematopoietic primary cells and services to cell therapy and life science researchers based on our customized focus on consistent, high quality product derived from profiled donors and drawn in our own FDA registered collection center. HemaCare also supports cell therapy development, clinical trials and commercialization with customized apheresis collections and provides a wide range of consulting services in SOP development, personnel training, quality and regulatory compliance. Learn more or view our Company Overview Presentation.
HemaCare provides a variety of quality, controlled, consistent, viable human primary cells and blood components derived from an assortment of tissues. Our cell processing lab is capable of purifying lymphocytes, monocytes, neutrophils, CD34+ stem cells, and much more!
Quality of living cellular raw material is a major determinant of final product characteristics. Controlling and qualifying the cell collection step is essential to minimizing operational sources of variability, and greatly increases the likelihood of success in manufacturing. HemaCare’s specialty is apheresis collection, and, building on over 35 years of experience, has addressed this need for optimized cell collection with a program for controlling and qualifying its apheresis procedures and collection sites, bringing a higher degree of reproducibility to research projects or manufacturing efforts based on cGMP and cGTP principles.
THERAPEUTIC APHERESIS SAMPLE ORDER FORMS
Mon, 12 Oct 2015 20:00:07 +0000
Wed, 07 Oct 2015 20:00:22 +0000
Mon, 05 Oct 2015 20:00:03 +0000
Wed, 30 Sep 2015 20:00:42 +0000
Mon, 28 Sep 2015 20:00:14 +0000
Wed, 23 Sep 2015 20:00:32 +0000
Mon, 21 Sep 2015 20:00:52 +0000
Wed, 16 Sep 2015 20:00:45 +0000
Mon, 14 Sep 2015 20:00:02 +0000
Wed, 09 Sep 2015 20:00:32 +0000
E-NEWSLETTER SIGN UP